Treasury Chief Rachel Reeves Intends Specific Action on Living Costs in Upcoming Budget
Treasury head Reeves has revealed she is preparing "specific action to tackle household expense challenges" in next month's Budget.
In comments to the BBC, she emphasized that reducing inflation is a collective responsibility of both the government and the Bank of England.
The United Kingdom's inflation rate is projected to be the highest among the G7 developed nations this calendar year and the following year.
Possible Utility Cost Interventions
Sources suggest the administration could take action to bring down utility costs, such as by reducing the present 5% rate of VAT charged on energy supplies.
A further approach is to lower some of the regulatory levies presently included in household expenses.
Fiscal Constraints and Analyst Predictions
The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for these actions.
The expectation from most experts is that the Chancellor will have to introduce tax rises or expenditure reductions in order to fulfill her declared debt limits.
Previously on Thursday, analysis showed there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the more modest range of forecasts.
"There's a collective task between the central bank and the government to continue tackling some of the drivers of inflation," the Chancellor told reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.
Tax Commitments and Global Issues
While much of the attention has been on probable tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her pledge to manifesto promises not to increase rates on earnings tax, VAT or social security contributions.
She attributed an "unpredictable global environment" with growing geopolitical and commercial tensions for the fiscal tax moves, probably to be directed on those "most able to pay."
Global Economic Tensions
Referring to apprehensions about the UK's economic relations with China she said: "Our national security always come first."
Last week's statement by China to tighten export controls on critical minerals and other materials that are key for high-technology manufacturing led US President Donald Trump to propose an extra 100% tariff on imports from the Asian country, raising the prospect of an full-scale trade war between the two economic giants.
The US Treasury Secretary called China's action "economic coercion" and "a global supply chain power grab."
Inquired about accepting the US offer to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's measures and urged the Beijing authorities "to avoid restrictions and restrict access."
She said the action was "bad for the international commerce and generates additional challenges."
"In my view there are areas where we should address China, but there are also important opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that balance correct."
The chancellor also affirmed she was working with G7 counterparts "on our own essential resources approach, so that we are reduced dependence."
NHS Drug Pricing and Investment
Reeves also acknowledged that the cost the National Health Service pays for medicines could go up as a result of ongoing discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and capital.
A number of the world's largest drug companies have said lately that they are either halting or abandoning projects in the United Kingdom, with some blaming the insufficient payments they are getting.
Last month, the government science advisor said the cost the health service spends on medicines would need to go up to halt businesses and pharmaceutical investment leaving the UK.
Reeves informed the BBC: "We have seen because of the payment system, that clinical trials, recent pharmaceuticals have not been provided in the UK in the manner that they are in other EU nations."
"Our aim is to guarantee that people getting treatment from the NHS are able to access the top life-saving treatments in the globe. And so we are looking at all of that, and... aiming to secure more investment into Britain."